University of Maryland, Department of Pharmaceutical Sciences, 20 Penn Street, Baltimore, MD 21201, USA.
University of Maryland, Department of Pharmaceutical Sciences, 20 Penn Street, Baltimore, MD 21201, USA.
Eur J Pharm Sci. 2022 Jun 1;173:106179. doi: 10.1016/j.ejps.2022.106179. Epub 2022 Mar 30.
A model was previously derived to predict in vitro dissolution of drug into surfactant solution and showed good predictability for pharmaceutical surfactants, where surfactant-mediated enhanced drug dissolution was several fold less than enhanced solubility (about 3-fold or less) due to drug-loaded micelles exhibiting slower diffusivity than free drug. The present objective was to quantitatively assess the contributions of biorelevant media-mediated solubility and diffusivity on enhanced drug dissolution in FeSSGF and FeSSIF-V2. Three poorly water soluble drugs were subjected to dissolution into FeSSGF and FeSSIF-V2, as well as their corresponding "surfactant-free" media. Solubility and laser diffraction analysis of drug in FeSSGF and dynamic light-scattering studies (DLS) of drug in FeSSIF-V2 were conducted. Results showed drug-saturated FeSSGF globules and FeSSIF-V2 mixed micelles were large and slow diffusing (diffusivities of about 1×10 and 7×10 cm/s, respectively), compared to free drug (about 7×10 cm/s) and drug-bound micelles from pharmaceutical surfactants (about 0.5-1×10 cm/s). Of the three drugs, griseofulvin exhibited the greatest biorelevant media-enhanced solubility and dissolution (652-fold and 6.23-fold respectively in FeSSGF, and 190-fold and 12.7-fold respectively in FeSSIF-V2), but slow colloid diffusivity markedly attenuated large solubility benefits, particularly in FeSSGF.
先前已经建立了一个模型,用于预测药物在表面活性剂溶液中的体外溶解情况,并且对医药用表面活性剂具有良好的预测能力,其中由于载药胶束的扩散性比游离药物慢,因此表面活性剂介导的药物增溶作用(增强溶解度约 3 倍或更少)远小于药物增溶作用。本研究的目的是定量评估生物相关介质介导的溶解度和扩散性对 FeSSGF 和 FeSSIF-V2 中药物增溶的贡献。将三种疏水性差的药物分别溶解在 FeSSGF 和 FeSSIF-V2 中,以及它们各自的“无表面活性剂”介质中。在 FeSSGF 和 FeSSIF-V2 中进行了药物的溶解度和激光衍射分析,以及在 FeSSIF-V2 中进行了药物的动态光散射(DLS)研究。结果表明,与游离药物(约 7×10 cm/s)和药物结合的药用表面活性剂胶束(约 0.5-1×10 cm/s)相比,药物饱和的 FeSSGF 胶束和 FeSSIF-V2 混合胶束较大且扩散缓慢(扩散系数分别约为 1×10 和 7×10 cm/s)。在这三种药物中,灰黄霉素表现出最大的生物相关介质增强的溶解度和溶解(在 FeSSGF 中分别为 652 倍和 6.23 倍,在 FeSSIF-V2 中分别为 190 倍和 12.7 倍),但胶体扩散缓慢明显削弱了大溶解度的优势,尤其是在 FeSSGF 中。